CD33 and neoplasm: Following preconditioning with busulfan and PDX tumor inoculation, treatment was initiated on day 10 with treatment arms including vehicle, [225Ac]DOTA-anti-CD33, and [225Ac]Macropa-PEG4-7065 group (Figure 8A).